CTNND1-DDAH2 Fusion FISH Probe
The CTNND1-DDAH2 Fusion FISH Probe is used to confirm a fusion of the CTNND1 and DDAH2 genes. The fusion of the CTNND1 and DDAH2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CTNND1-DDAH2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CTNND1-DDAH2-20-AQAQ | 20 (40 μL) | 200 μL |
|
CTNND1 Gene Summary
This gene encodes a member of the Armadillo protein family, which function in adhesion between cells and signal transduction. Multiple translation initiation codons and alternative splicing result in many different isoforms being translated. Not all of the full-length natures of the described transcript variants have been determined. Read-through transcription also exists between this gene and the neighboring upstream thioredoxin-related transmembrane protein 2 (TMX2) gene. [provided by RefSeq, Dec 2010]
Gene Name: Catenin Delta 1
Chromosome: CHR11: 57529233 -57586652
Locus: 11q12.1
DDAH2 Gene Summary
This gene encodes a dimethylarginine dimethylaminohydrolase. The encoded enzyme functions in nitric oxide generation by regulating the cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. The protein may be localized to the mitochondria. Alternative splicing resulting in multiple transcript variants. [provided by RefSeq, Dec 2014]
Gene Name: Dimethylarginine Dimethylaminohydrolase 2
Chromosome: CHR6_qbl_hap6: 2988446 -2991669
Locus: 6p21.33
Gene Diseases
The CTNND1 DDAH2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|